358 related articles for article (PubMed ID: 31987674)
21. BRAF V600E mutation-specific immunohistochemical analysis in ameloblastomas: a 44-patient cohort study from a single institution.
Owosho AA; Ladeji AM; Adebiyi KE; Olajide MA; Okoye ISI; Kehinde T; Nwizu NN; Summersgill KF
Eur Arch Otorhinolaryngol; 2021 Aug; 278(8):3065-3071. PubMed ID: 33231757
[TBL] [Abstract][Full Text] [Related]
22. The immunoprofile of odontogenic keratocyst (keratocystic odontogenic tumor) that includes expression of PTCH, SMO, GLI-1 and bcl-2 is similar to ameloblastoma but different from odontogenic cysts.
Vered M; Peleg O; Taicher S; Buchner A
J Oral Pathol Med; 2009 Aug; 38(7):597-604. PubMed ID: 19473442
[TBL] [Abstract][Full Text] [Related]
23. Absence of BRAFV600E mutation in odontogenic keratocysts.
França JA; de Sousa SF; Diniz MG; Pereira TDSF; de Resende TAC; Santos JND; Gomez RS; Gomes CC
J Oral Pathol Med; 2018 Feb; 47(2):186-191. PubMed ID: 29272070
[TBL] [Abstract][Full Text] [Related]
24. Twist expression in dentigerous cyst, odontogenic keratocyst, and ameloblastoma.
Andisheh-Tadbir A; Pardis S; Ranjbaran P
Oral Maxillofac Surg; 2015 Mar; 19(1):103-7. PubMed ID: 25088731
[TBL] [Abstract][Full Text] [Related]
25. HSP70 expression in dentigerous cyst, odontogenic keratocyst, and ameloblastoma.
Andisheh-Tadbir A; Fakharian M
Oral Maxillofac Surg; 2015 Sep; 19(3):287-91. PubMed ID: 25854321
[TBL] [Abstract][Full Text] [Related]
26. Identification of BRAF V600E mutation in odontogenic tumors by high-performance MALDI-TOF analysis.
Togni L; Zizzi A; Mazzucchelli R; Santarelli A; Rubini C; Mascitti M
Int J Oral Sci; 2022 Apr; 14(1):22. PubMed ID: 35468886
[TBL] [Abstract][Full Text] [Related]
27. BRAF p.V600E mutations are not unique to ameloblastoma and are shared by other odontogenic tumors with ameloblastic morphology.
Brunner P; Bihl M; Jundt G; Baumhoer D; Hoeller S
Oral Oncol; 2015 Oct; 51(10):e77-8. PubMed ID: 26306423
[No Abstract] [Full Text] [Related]
28. Should the solid variant of odontogenic keratocyst and keratoameloblastoma be classified as the same entity? A clinicopathological analysis of nine cases and a review of the literature.
Zhang R; Yang J; Zhang J; Hong Y; Xie X; Li T
Pathology; 2021 Jun; 53(4):478-486. PubMed ID: 33551126
[TBL] [Abstract][Full Text] [Related]
29. Whole Exome Sequencing of
Shimura M; Nakashiro KI; Sawatani Y; Hasegawa T; Kamimura R; Izumi S; Komiyama Y; Fukumoto C; Yagisawa S; Yaguchi E; Hitomi-Koide M; Hyodo T; Uchida D; Kawamata H
In Vivo; 2020; 34(6):3233-3240. PubMed ID: 33144428
[TBL] [Abstract][Full Text] [Related]
30. PTCH1 alterations are frequent but other genetic alterations are rare in sporadic odontogenic keratocysts.
Qu J; Zhang J; Zhang H; Li X; Hong Y; Zhai J; Wang Y; Chen F; Li T
Oral Dis; 2019 Sep; 25(6):1600-1607. PubMed ID: 31162759
[TBL] [Abstract][Full Text] [Related]
31. High prevalence of BRAF V600E mutations in Korean patients with ameloblastoma: Clinicopathological significance and correlation with epithelial-mesenchymal transition.
Oh KY; Cho SD; Yoon HJ; Lee JI; Ahn SH; Hong SD
J Oral Pathol Med; 2019 May; 48(5):413-420. PubMed ID: 30889301
[TBL] [Abstract][Full Text] [Related]
32. Genetic study of the BRAF gene reveals new variants and high frequency of the V600E mutation among Iranian ameloblastoma patients.
Soltani M; Tabatabaiefar MA; Mohsenifar Z; Pourreza MR; Moridnia A; Shariati L; Razavi SM
J Oral Pathol Med; 2018 Jan; 47(1):86-90. PubMed ID: 28650588
[TBL] [Abstract][Full Text] [Related]
33. Frequency of BRAF V600E mutation in a group of Thai patients with ameloblastomas.
Lapthanasupkul P; Laosuk T; Ruangvejvorachai P; Aittiwarapoj A; Kitkumthorn N
Oral Surg Oral Med Oral Pathol Oral Radiol; 2021 Nov; 132(5):e180-e185. PubMed ID: 32665205
[TBL] [Abstract][Full Text] [Related]
34. Assessing pathogenic mutations in dental follicles as an attempt to identify early events in odontogenic tumours tumourigenesis.
Coura BP; de Resende TAC; de Menezes VCB; Bernardes VF; de Sousa SF; Diniz MG; Gomez RS; Gomes CC
Arch Oral Biol; 2020 May; 113():104523. PubMed ID: 31543246
[TBL] [Abstract][Full Text] [Related]
35. Adenoid Ameloblastoma with BRAF p.V600E Mutation Revealing Ameloblastomatous Origin: A First Case Report.
Noda Y; Sawada S; Sakagami T; Kojima Y; Higasa K; Tsuta K
Head Neck Pathol; 2023 Sep; 17(3):788-792. PubMed ID: 37093491
[TBL] [Abstract][Full Text] [Related]
36. Does BRAF V600E mutation affect recurrence rate of ameloblastomas? Systematic review and meta-analysis.
Martins-de-Barros AV; Silva CCG; Gonçalves KKN; de Albuquerque Cavalcanti Almeida R; de Oliveira E Silva ED; da Costa Araújo FA; Robinson L; van Heerden WFP; de Vasconcelos Carvalho M
J Oral Pathol Med; 2023 Sep; 52(8):701-709. PubMed ID: 37364158
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical analysis of BRAF V600E mutation in ameloblastomas.
do Canto AM; da Silva Marcelino BMR; Schussel JL; Wastner BF; Sassi LM; Corrêa L; de Freitas RR; Hasséus B; Kjeller G; Junior CAL; Braz-Silva PH
Clin Oral Investig; 2019 Feb; 23(2):779-784. PubMed ID: 29855709
[TBL] [Abstract][Full Text] [Related]
38. Differential expression of PEA3 in odontogenic cysts and tumors.
Tun KM; Kitkumthorn N; Bumalee D; Arayapisit T; Lapthanasupkul P
J Oral Pathol Med; 2023 Sep; 52(8):777-785. PubMed ID: 37549030
[TBL] [Abstract][Full Text] [Related]
39. High frequency of BRAF V600E mutations in ameloblastoma.
Kurppa KJ; Catón J; Morgan PR; Ristimäki A; Ruhin B; Kellokoski J; Elenius K; Heikinheimo K
J Pathol; 2014 Apr; 232(5):492-8. PubMed ID: 24374844
[TBL] [Abstract][Full Text] [Related]
40. An immunohistochemical and genetic study of BRAF
Seki-Soda M; Sano T; Ito K; Yokoo S; Oyama T
Pathol Int; 2020 Apr; 70(4):224-230. PubMed ID: 31930640
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]